China CAS NO 2180-92-9 Factory

Assume full accountability to meet all requires of our purchasers; realize continual advancements by selling the advancement of our customers; grow to be the final permanent cooperative partner of consumers and maximize the interests of clientele for CAS NO 2180-92-9,2180-92-9,Bupivacaine API,Bupivacaine, Never-ending improvement and striving for 0% deficiency are our two main quality policies. Should you need anything, don't hesitate to contact us.
CAS NO 2180-92-9, Our company regards "reasonable prices, efficient production time and good after-sales service" as our tenet. We hope to cooperate with more customers for mutual development and benefits. We welcome potential buyers to contact us.

Hot Products

  • Tucatinib N-1

    Tucatinib N-1

    Product Name:Tucatinib N-1
    Molecular Formula:C26H26N8O2S
    Molecular Weight:514.6
    CAS Registry Number:1429755-58-7
  • Pseudouridine

    Pseudouridine

    Product Name:Pseudouridine
    Molecular Formula:C9H12N2O6
    Molecular Weight;244.2
    CAS Registry Number;1445-07-4
  • Perfluorotripropylamine

    Perfluorotripropylamine

    Product Name:Perfluorotripropylamine
    Molecular Formula:C9F21N
    Molecular Weight:521.07
    CAS Registry Number:338-83-0
  • Dinoprost Trometamol

    Dinoprost Trometamol

    Product Name:Dinoprost Trometamol
    Molecular Formula:C24H45NO8
    Molecular Weight:475.62
    CAS Registry Number:38562-01-5
  • 3-aminophthalic acid hydrochloride dihydrate

    3-aminophthalic acid hydrochloride dihydrate

    Product Name:3-aminophthalic acid hydrochloride dihydrate
    Molecular Formula:C8H8ClNO4
    Molecular Weight:217.61
    CAS Registry Number:6946-22-1
  • 2-Chloro-1,4-naphthoquinone

    2-Chloro-1,4-naphthoquinone

    Product Name:2-Chloro-1,4-naphthoquinone
    Molecular Formula:C10H5ClO2
    Molecular Weight:192.6
    CAS Registry Number:1010-60-2

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept